MedPath

Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases

Completed
Conditions
Eye Diseases
Interventions
Diagnostic Test: Multimodal Machine Learning Program for Auxiliary Diagnosis of Eye Diseases
Registration Number
NCT05930444
Lead Sponsor
Eye & ENT Hospital of Fudan University
Brief Summary

With rapid advancements in natural language processing and image processing, there is a growing potential for intelligent diagnosis utilizing chatGPT trained through high-quality ophthalmic consultation. Furthermore, by incorporating patient selfies, eye examination photos, and other image analysis techniques, the diagnostic capabilities can be further enhanced. The multi-center study aims to develop an auxiliary diagnostic program for eye diseases using multimodal machine learning techniques and evaluate its diagnostic efficacy in real-world outpatient clinics.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9825
Inclusion Criteria
  • Informed consent obtained;
  • Participants should be able to have Chinese as their mother tongue, and be sufficiently able to read, write and understand Chinese;
  • For normal participants: individuals should have no concerns related to their eyes.
  • For participants with eye-related chief complaints: individuals should have specific concerns or issues related to their eyes.
Exclusion Criteria
  • Incomplete clinical data to support final diagnosis;
  • Patients who, in the opinion of the attending physician or clinical study staff, are too medically unstable to participate in the study safely.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Eye-related Chief ComplaintsMultimodal Machine Learning Program for Auxiliary Diagnosis of Eye DiseasesIndividuals who have specific concerns or issues related to their eyes, which they consider as the main reason for seeking medical attention or making a complaint.
Primary Outcome Measures
NameTimeMethod
Diagnostic accuracy of multimodal machine learning programfrom July 2023 to March 2024

For each patient, the diagnoses generated by the multimodal machine learning program and the clinical diagnosis provided by skilled clinicians were documented and compared. Consistency between the two diagnoses indicates the program's precision in clinical practice.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

The Affiliated Eye Hospital of Nanjing Medical University

🇨🇳

Nanjing, China

Suqian First People's Hospital

🇨🇳

Suqian, China

Fudan Eye & ENT Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath